Electrification in life sciences is emerging as a strategic imperative beyond mere carbon reduction. New research reveals it ...

Wave Life Sciences has lost nearly 70% of its value this year, and its RNA platform could make it irresistible to the right ...

The equity portion of the Fund rose (gross of fees) and outperformed its benchmark, the NASDAQ Biotechnology Index. Read more ...

Accomplished life sciences executive brings more than 20 years' experience of CDMO and pharmaceutical leadership to guide Life Sciences division MINNEAPOLIS, MN / ACCESS Newswire / August 13, 2026 / ...

Nominations are now open for the 2026 Fiercest Women in Life Sciences. | Who should be a 2026 Fiercest Woman in Life Sciences ...

Wesleyan University has named its new science building the Casper Life Sciences Building in honor of Marc Casper ’90, P’23 ...

Life sciences organisations generate data at extraordinary speed, but insight remains slow. Semantic knowledge graphs and ontologies address this by providing context and structur ...

Sellas Life Sciences Group (SLS) reported a wider second-quarter loss as the cancer-drug developer increased spending ahead ...

Wave Life Sciences (WVE) stock analysis: low valuation (2.45x cash, no debt) vs. RNA therapy competition; key upside tied to WVE-N531 results. See more here.

In this week’s edition of InnovationRx, we look at cancer breakthroughs from the ASCO conference, Clear’s move into healthcare, Harrison.ai’s U.S. expansion, and more. To get it in your inbox, ...